These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 18430617)
21. Effectiveness and safety of local adalimumab injection in patients with fistulizing perianal Crohn's disease: a pilot study. Tonelli F; Giudici F; Asteria CR Dis Colon Rectum; 2012 Aug; 55(8):870-5. PubMed ID: 22810472 [TBL] [Abstract][Full Text] [Related]
22. Cost-utility analysis of biologic treatments for moderate-to-severe Crohn's disease. Tang DH; Armstrong EP; Lee JK Pharmacotherapy; 2012 Jun; 32(6):515-26. PubMed ID: 22528603 [TBL] [Abstract][Full Text] [Related]
23. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease. Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204 [TBL] [Abstract][Full Text] [Related]
24. Increased response and remission rates in short-duration Crohn's disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data. Schreiber S; Colombel JF; Bloomfield R; Nikolaus S; Schölmerich J; Panés J; Sandborn WJ; Am J Gastroenterol; 2010 Jul; 105(7):1574-82. PubMed ID: 20234346 [TBL] [Abstract][Full Text] [Related]
25. Maintenance of remission in Crohn's disease: current and emerging therapeutic options. Brookes MJ; Green JR Drugs; 2004; 64(10):1069-89. PubMed ID: 15139787 [TBL] [Abstract][Full Text] [Related]
26. A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease. Schreiber S; Rutgeerts P; Fedorak RN; Khaliq-Kareemi M; Kamm MA; Boivin M; Bernstein CN; Staun M; Thomsen OØ; Innes A; Gastroenterology; 2005 Sep; 129(3):807-18. PubMed ID: 16143120 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of adalimumab in Crohn's disease: meta-analysis of placebo-controlled trials. Huang ML; Ran ZH; Shen J; Li XB; Xu XT; Xiao SD J Dig Dis; 2011 Jun; 12(3):165-72. PubMed ID: 21615869 [TBL] [Abstract][Full Text] [Related]
35. Certolizumab pegol: a polyethylene glycolated Fab' fragment of humanized anti-tumor necrosis factor alpha monoclonal antibody for the treatment of Crohn's disease. Baker DE Rev Gastroenterol Disord; 2008; 8(4):240-53. PubMed ID: 19107098 [TBL] [Abstract][Full Text] [Related]
36. [Adalimumab for the treatment of Crohn's disease - consensus paper of the Working Group "chronic inflammatory bowel diseases" of the Austrian Society for Gastroenterology and Hepatology]. Reinisch W; Haas T; Kaser A; Petritsch W; Vogelsang H; Feichtenschlager T; Novacek G; Siebert F; Tilg H; Knoflach P Z Gastroenterol; 2009 Apr; 47(4):372-80. PubMed ID: 19358065 [TBL] [Abstract][Full Text] [Related]
37. Efficacy of adalimumab in moderate-to-severe pediatric Crohn's disease. Viola F; Civitelli F; Di Nardo G; Barbato MB; Borrelli O; Oliva S; Conte F; Cucchiara S Am J Gastroenterol; 2009 Oct; 104(10):2566-71. PubMed ID: 19550415 [TBL] [Abstract][Full Text] [Related]
38. Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease. de Rossi TM; Krauss N; Voll RE; Nägel A; Weidenhiller M; Konturek PC; Hahn EG; Raithel M Digestion; 2008; 78(4):195-200. PubMed ID: 19122456 [TBL] [Abstract][Full Text] [Related]
39. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics. Mahadevan U; Cucchiara S; Hyams JS; Steinwurz F; Nuti F; Travis SP; Sandborn WJ; Colombel JF Am J Gastroenterol; 2011 Feb; 106(2):214-23; quiz 224. PubMed ID: 21157441 [TBL] [Abstract][Full Text] [Related]
40. Review article: Medical therapy for fistulizing Crohn's disease. Bressler B; Sands BE Aliment Pharmacol Ther; 2006 Nov; 24(9):1283-93. PubMed ID: 17059510 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]